chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Narrative:  Patient is a 73 YOM who presented to ED on 2/10/2021 following his first COVID-19 vaccination at an outside hospital the day before. The patient was complaining of right-sided weakness and slurred speech starting about 2 hours prior to his presentation. In the ED, patient was found to have a TIA and was admitted to the floor for further care. The patient was hospitalized from 2/10/2021 to 2/12/2021, at which time he was noted to be back at baseline and was discharged home. Because the patient received his vaccination at a non agency hospital, there is no vaccination information I am able to report.
Patient experienced itchiness at the site of the injection under the bandaid and PPE. She was given benadryl orally and did not complain of the event any further in the 6 hours I saw her.
"node still quite enlarged. A bit painful"; very enlarged lymph node neck/collarbone; fingers tingling; hands/feet/scalp itchy; Chills; Fever 101.3F; Headache; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 06Apr2021 at 15:30 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient's medical history included irritable bowel syndrome with constipation, seasonal allergy and sulfonamide allergy. Concomitant medications included levonorgestrel (MIRENA) and psyllium hydrophilic mucilloid (METAMUCIL) from unknown start dates for unknown indications and unknown if ongoing. The patient previously took Keflex and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on an unknown date at 15:30 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Lab tests and procedures included body temperature test on 06Apr2021 and the result was found to be 101.3F. On 06Apr2021 the patient had "normal" side effects in first two days which included chills (8 hours after vaccine) followed by fever (101.3F) and headache. On 09Apr2021, third day after vaccine, the patient developed very enlarged lymph node on neck/collarbone; fingers tingling and hands/feet/scalp itchy. On 12Apr2021, 6 days post vaccine, itchiness had declined but node still quite enlarged and bit painful. Since the vaccination, the patient had not been tested for COVID-19. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events chills, fever 101.3F, headache, very enlarged lymph node neck/collarbone, fingers tingling and "node still quite enlarged. A bit painful" was recovering. The clinical outcome of the event hands/feet/scalp itchy was recovered on 12Apr2021.  No follow-up attempts are needed. No further information is expected.
Pain in right upper arm muscle since vaccine administration. Decreased range of motion secondary to pain. Can't move arm without pain. Decreased strength in right arm.
Two weeks after vaccine I started to feel dizzy, my heart was racing and I was short of breath. Reached out to Primary doctor but hadn't gone in for the appointment yet. Ended up going to the Emergency Room. Did an EKG and a CT Scan, blood work up, and everything was negative. Was sent me home with hydroxyzine and meclizine medication, but was still feeling the same way. Went to see my Primary doctor and was given gave ZOLOFT for Anxiety and a Heart Monitor. Wore for 10 days and everything looked normal. Went to an ENT to test for Vertigo, and it was negative. I was still constantly dizzy and couldn't drive. Then the ENT referred me to a Cardiologist. Went to Cardiologist and was given another another EKG and it came back negative. Afterwards I started feeling weird like nerve pain was constantly moving throughout my body and I couldn't sleep. I went to a Chiropractor, and was given a supplement, don't remember the name and an antihistamine. After this I started feeling a little better and was able to sleep. I'm still feeling dizzy to this day and feeling numbness on my right side. Working with my insurance to get to see if I can an appointment with a Neurologist.
For 4 hours after vaccine- heart racing, palpitations and beating odd, very cold and very shaky took symptoms began 1 hour after vaccine and I took 2 Benadryl 1 hour after vaccine . I was close to going to emergency room but didn?t- later in the day other symptoms happened In left eye and hearing , For several months after - left eye pain and couldn?t totally close eye lid, eye felt inflamed and hurt eye to watch tv, day of vaccine developed floaters in left eye as well,  sounds were distorted and I heard an echo when I talked. Sounded like I was under water .  Went to eye dr who did an exam and said my eye looks healthy .  Told primary dr about reaction . Now in November 2021  intensity of issues getting much better but still have left eye pain and still feels like I?m underwater when talking and still have floaters in left eye
slight anaphylaxis reaction; difficulty swallowing; swelling at the injection; A spontaneous report was received from a consumer concerning a female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced slight anaphylaxis, difficulty swallowing and swelling at the injection.   The patient's medical history was not provided. No relevant concomitant medications were reported.  On an unknown date patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.   Patient called to inquire about the second dose. She stated she had a slight anaphylaxis reaction. When quired for more details regarding her event she mentioned that it was sort of difficulty swallowing, which didn't last long and some swelling at the injection.   No treatment information was provided.  Action taken with RNA-1273 in response to the event was unknown.  The event difficulty in swallowing was considered as resolved. The outcome of the event slight anaphylaxis and swelling at the injection was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the events, a causal relationship cannot be excluded.
SLIGHT REDNESS AT INJECTION SITE WITH TENDERNESS, INDURATION AND INCREASED HEAT IN AREA. CEPHALEXIN 500 MG 1 TAB PO BID FOR 5 DAYS, AND IBUPROFEN 400 MG PO Q6H.
Severe pain in my stomach. I experienced  bloating, vomiting's and diarreha. That lead me to go to the hospital, which I spent 4 days. They had me on medication to stop the pain. I was diagnosis with gastritis.
02/16/2022- 05:00PM ET- Chest pain and tingling in the left arm. 02/17/2022- Chest pain was really strong and the tingling is now in both arms. 02/17/2022- Went to the doctor. 02/17/2022- Left head pain and stomach pain.
Resident noted to have mild swelling & circular erythema, measures at approximately 6x5 cm to L deltoid muscle at vaccination site. Denies pain on palpation. Small scratch marks noted to site, denies itching when assessing.  Will treat by applying warm compress to site for 20-30 mins PRN q hour x 3 days, then reassess site. Treat with PRN tylenol order for pain.
Snycope /w brief LOC, tonic/clonic movements, decreased BP, pallor, diaphoretic Place on exam table in trendelenburg position. Monitored vital signs
1 day post vax pt broke out in a rash-change to hives day #2;
Severe pain started 2/10 and radiated slowly from the left shoulder across the back almost to R shoulder. The neck muscles were very painful. The only swelling was local at inj. site. The pain was severe. TYLENOL helped along with local heat. The pain increased daily from 2/10 until it stopped on 2/17. No fever or GI issues.
Pt reported SOB, asthma like exacerbation, wheezing, feeling like throat was closing about 1 hour after vaccine. Reported taking home inhalers. Denied going to the emergency room or LOC Pt now feels good, at baseline
3/07/17 was seen for severe hives, was given SOLU-MEDROL 40mg/mL. Administered 0.5 mL in office. Prescribed prednisolone 15mg/5mL solution: Take 2.5mL twice a day by oral route for 5 days.
left underarm and side of left breast ache (lymph nodes) but no noticeable swelling, just pain. Pain at injection site and arm muscle, some numbness in left wrist, aching tailbone and lower back as well as other large joints, and Headache
Patient states that in the afternoon after receiving vaccines she could not get off her couch without assistance. She said she was achy, dizzy, extreme fatigue and headache. She had chills but head felt hot. She did not  take temperature. She was able to get up around 10 AM the next morning. She experience diarrhea the  day after vaccines. She said it took her 3 to 4 days to feel normal.
Pain in chest and back for two weeks, black out Nov. 13, 2021 and went to hospital ER thought I was having a heart attack, EKG normal and blood work came back normal and diagnose with Syncope. Weakness, fatigue, dizziness, light headed, and continued chest pain that I couldn't do normal activities. Went to GP Nov. 16, 2021, scheduled more blood tests and Echocardiogram. All test results came back normal. Saw GP Nov. 23, 2021. Diagnosed with Costochonditis and given 10 day supply of meloxicam.  Slowly day by day symptoms are leaving, but still have fatigue. Dec. 1, 2021 saw GP and will take another 10 day of meloxicam.
Information has been received from a nurse referring to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On 12-APR-2016 the patient was vaccinated with an improperly stored dose of MMR II (lot#I023386, expiration date 25-JUN-2017, dose and route unknown) and an improperly stored dose of (Oka/Merck) VARIVAX (lot# reported as I04688, expiration date 23-NOV-2017, dose and route unknown). The temperature and time frame were at 14.9 Celsius degree for 280 hours. There was no out of range before. No adverse events were reported. Lot number I04688 is an invalid lot number for (Oka/Merck) VARIVAX. This is one of several reports received from the same reporter. Additional information has been requested.
cough, body aches, sore throat, runny nose, fatigue, headache, diarrhea,. starting 12/17/21
Information has been received from a registered nurse concerning an 18 year old patient who on 29-MAY-2012 was vaccinated with a dose of ZOSTAVAX (Merck) instead of VARIVAX (Merck). The nurse practitioner prescribed the ZOSTAVAX (Merck) for the patient. No product confusion discovered. No adverse event reported. Follow-up information was received from registered nurse refers to 18 years old female student. No other co-suspects were reported. No concomitant medications were reported. The patient did not seek medical attention. No adverse event reported. Additional information is not expected.
Intense intestinal upset and pain in lower abdomen coupled with gas and constant diarrhea; Intense intestinal upset and pain in lower abdomen coupled with gas and constant diarrhea; Intense intestinal upset and pain in lower abdomen coupled with gas and constant diarrhea; Intense intestinal upset and pain in lower abdomen coupled with gas and constant diarrhea; Continual pain all the next day with continued symptoms; This is a spontaneous report from a contactable consumer (patient). A 25-year-old female patient (pregnant: No) received first dose of bnt162b2, via an unspecified route of administration in left arm on 06Feb2021 14:45 at single dose for COVID-19 immunization. Medical history included depression from an unknown date and unknown if ongoing.  Concomitant medication included trazodone, venlafaxine, birth control. The patient experienced intense intestinal upset and pain in lower abdomen coupled with gas and constant diarrhea, continual pain all the next day with continued symptoms on 06Feb2021 04:00 (as reported). Intense intestinal upset and pain in lower abdomen coupled with gas and constant diarrhea. had to sit on the toilet solidly for over an hour in the middle of the night and has continual pain all the next day with continued symptoms. The outcome of events was not resolved. The adverse event was not resulted in a visit to doctor or other healthcare professional office/clinic or Emergency room/department or urgent care. No treatment received for adverse events. Facility type vaccine: Other. No other vaccine in four weeks. Other medications in two weeks included: trazodone, venlafaxine, birth control. No COVID prior vaccination. No COVID tested post vaccination. No known allergies.  Information about batch/lot number has been requested.
This spontaneous report as received from a nurse refers to an 11 years 4 months old male patient. No concurrent condition, medical history or allergy/drug reactions were reported. On an unspecified date, the patient was vaccinated with improperly stored (exposed to 52.8 Fahrenheit for a total of 105 hours) GARDASIL injection, lot # K005881, exp. date: 14-JAN-2017 (dose, strength and route unspecified). No concomitant medications were reported. No adverse experiences have been reported so far. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information is not expected, no contact details were provided.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare providers recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. In 2008, a healthcare provider administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). In 2011, the patient was treated by a healthcare provider for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
40 second episode of unresponsiveness and eyes rolling up.  Seen in emergency room.  Diagnosed probable febrile seizure.  No prescription given.  patient had a fever for 2 days.
Received DTAP in left deltoid. On May 6 had baseball sized swollen, red area that was warm to touch. Mother had been using Tylenol and cool compresses.
On 1/27/2023, patient presented to the emergency department for evaluation of jaundice and chest pain. He had a positive COVID-19 NAA test but notably he did not have any COVID symptoms; His chest x-ray showed minimal plate-like atelectasis in the right lung base but there was no evidence of active pulmonary disease. Patient had an ultrasound of the liver/gallbladder/pancreas which showed that his gallbladder was distended with multiple gallstones and the common bile duct was slightly distended. He was diagnosed with cholecystitis and COVID-19 and admitted to the hospital for further treatment. Patient had a cholecystectomy on 1/29/2023. Postoperatively, the patient?s condition deteriorated. He coded and then died on 1/29/2023 while an inpatient at the hospital. Web Report received from the hospital indicated COVID-19 as a cause of death.    Submitter does not have access to further medical information on this case. If more information is needed, please contact the admitting hospital.
pt recvd vax & had sz; pt taken to hosp & t 104; pt dx w/ febrile sz vs adverse rxn to vax;
No additional AE; HCP who is medical technologist lab manager reported an adverse event for VARIVAX. Caller explained VARIVAX was delivered on 07JUN2022 after the receive by date of 06JUN2022 and was administered to a patient. Caller did not have any further clarifyin; This spontaneous report was received from a medical technologist lab manager referring to a patient of unknown age and gender. the patient's concurrent conditions, medical history and concomitant therapies were not reported. There was no information regarding the patient's allergies or drug reactions.  On 07-JUN-2022, varicella virus vaccine live (oka/merck) (VARIVAX), lot number: W002599, expiration date: 24-JAN-2024 was delivered after the receive by date of 06-JUN-2022. On 15-JUN-2022, the patient was vaccinated with the improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) (dose, dose number, route of administration and anatomical location were not reported) for prophylaxis (product storage error). No additional adverse event (AE) or product quality complaint (PQC) was reported (no adverse event). There was no reported previous temperature excursion.
Strong medicine taste in the back of my mouth within 5 mins of injection. Over the next hour after the injection, the taste got stronger; Over the next hour after the injection, the taste got stronger and lead to a tingling sensation in the back of my throat and tongue; This is a spontaneous report from a contactable consumer (patient). A 47-year-old female patient received bnt162b2 (BNT162B2) Lot number: FH9899, via an unspecified route of administration on the right arm, first dose on 17Dec2020 08:15 at a single dose for immunization. Medical history included glucose-6-phosphate dehydrogenase deficiency (G6PD), gastrooesophageal reflux disease (GERD) and allergies to Sulfa which is contraindicated for G6PD. Concomitant medication included famotidine and cetirizine. The patient previously took methylcobalamin and quinine (which is contraindicated for G6PD), and experienced drug hypersensitivity on both. On 17Dec2020 at 08:30 AM, the patient experienced strong medicine taste in the back of her mouth within 5 mins of injection. Over the next hour after the injection, the taste got stronger and lead to a tingling sensation in the back of her throat and tongue. These 2 symptoms are still present 22 hrs after receiving the vaccination. The medicine taste and tingling has decreased from strong to mild over the 22 hours. She mentioned that she did not have Covid prior vaccination nor did she tested positive post vaccination. She did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The events were reported as non-serious. No treatment received and the patient was recovering from the 'Strong medicine taste' and 'Strong medicine taste'.
I was given the Pfizer Covid Bival (12YUP) EUA shot although I have never received the 2 dose premier shots. The appointment email clearly said I was scheduled to receive the Covid-19 (Pfizer - 1st dose)
patient reported lightheadedness and leg heaviness.  BP 153/102, HR 110-120, O2 100%. Patient was transferred to ER via stretcher.
He had a breakthrough case of Covid-19. He had fever chills, runny nose, coughing with congestion and confusion as well.
Severe hives over entire body, tightness in chest, lump in throat that over four days didn't respond much to treatment (benadryl, famotidine, prednisone). Significant and sustained improvement began on day 5, but I continue to get hives.
Myalgia, Arthralgia & Leukocytosis and shoulder joint effusion
Presented to ER on 8/19/06 with c/o pain in the L shoulder and axilla. He had received his smallpox vaccination approximately 10 days prior. Physical Exam noted: L axilla lymphadenopathy, reddened area to the L upper arm where smallpox vaccination had been given. Patient was afebrile. Additionally he c/o of some L upper lateral chest pain. A CXR and Labs were obtained. Dx: L axillary lymphadenopathy secondary to smallpox vaccination. Orders given for Ibuprofen 600mg q 6 hours, #8 were dispensed. Vicodin 5/500 one every 4-6  hours, #12 were dispensed. Patient was to follow up.
Blood clot in right calf.  Noticed pain and knot in calf on Sunday 3/14/2021.  It worsened over the next few days. Went to Urgent care on 3/18 and they sent us straight to ER for Ultrasound.   In hospital they found it was a clot identified as deep vein thrombosis, and started a treatment of blood thinner and pain medication.
Chills, fever, muscle aches, headache, sore arm...all symptoms lasting 24 hours
heat makes it burn; broke out in hives; painful; itchy; hundred bumps; very tender and heat makes it burn; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (broke out in hives), PAIN IN EXTREMITY (painful), PRURITUS (itchy), PILOERECTION (hundred bumps) and THERMAL BURN (very tender and heat makes it burn) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Aug-2021, the patient experienced URTICARIA (broke out in hives), PAIN IN EXTREMITY (painful), PRURITUS (itchy), PILOERECTION (hundred bumps) and THERMAL BURN (very tender and heat makes it burn). On an unknown date, the patient experienced BURNING SENSATION (heat makes it burn). The patient was treated with PREDNISONE at an unspecified dose and frequency and CALAMINE, ZINC OXIDE (CALADRYL [CALAMINE;ZINC OXIDE]) at an unspecified dose and frequency. At the time of the report, URTICARIA (broke out in hives), PAIN IN EXTREMITY (painful), PRURITUS (itchy), PILOERECTION (hundred bumps), THERMAL BURN (very tender and heat makes it burn) and BURNING SENSATION (heat makes it burn) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported by the Reporter. The treatment information were oat milk baths (Aveeno 100% oat milk), using ice packs, lotion.
Dull ache in left deltoid (injection site) X 1 year with occasional throbbing.
ON AND OFF TINGLING; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced on and off tingling. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of on and off tingling was not reported. This report was non-serious.
Achiness through upper torso plus a lump in arm pit of  left arm.   Rubbed self down with arnicare for achiness the day following shot, cleared up that situation within.  Iced the lump at the same time but still tender on 2nd day continue to ice off and on.